Cargando…
BCL-B (BCL2L10) is overexpressed in patients suffering from multiple myeloma (MM) and drives an MM-like disease in transgenic mice
Multiple myeloma (MM) evolves from a premalignant condition known as monoclonal gammopathy of undetermined significance (MGUS). However, the factors underlying the malignant transformation of plasmocytes in MM are not fully characterized. We report here that Eµ-directed expression of the antiapoptot...
Autores principales: | Hamouda, Mohamed-Amine, Jacquel, Arnaud, Robert, Guillaume, Puissant, Alexandre, Richez, Valentine, Cassel, Romeo, Fenouille, Nina, Roulland, Sandrine, Gilleron, Jerome, Griessinger, Emmanuel, Dubois, Alix, Bailly-Maitre, Beatrice, Goncalves, Diogo, Mallavialle, Aude, Colosetti, Pascal, Marchetti, Sandrine, Amiot, Martine, Gomez-Bougie, Patricia, Rochet, Nathalie, Deckert, Marcel, Avet-Loiseau, Herve, Hofman, Paul, Karsenti, Jean-Michel, Jeandel, Pierre-Yves, Blin-Wakkach, Claudine, Nadel, Bertrand, Cluzeau, Thomas, Anderson, Kenneth C., Fuzibet, Jean-Gabriel, Auberger, Patrick, Luciano, Frederic |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995074/ https://www.ncbi.nlm.nih.gov/pubmed/27455953 http://dx.doi.org/10.1084/jem.20150983 |
Ejemplares similares
-
BCL2L10 is a predictive factor for resistance to Azacitidine in MDS and AML patients
por: Cluzeau, Thomas, et al.
Publicado: (2012) -
A new posttranslational regulation of REDD1/DDIT4 through cleavage by caspase 3 modifies its cellular function
por: Puissant, A, et al.
Publicado: (2014) -
Severe Thymic Atrophy in a Mouse Model of Skin Inflammation Accounts for Impaired TNFR1 Signaling
por: Belhacéne, Nathalie, et al.
Publicado: (2012) -
The small heat shock protein B8 (HSPB8) confers resistance to bortezomib by promoting autophagic removal of misfolded proteins in multiple myeloma cells
por: Hamouda, Mohamed-Amine, et al.
Publicado: (2014) -
Dual targeting of BCL2 and MCL1 rescues myeloma cells resistant to BCL2 and MCL1 inhibitors associated with the formation of BAX/BAK hetero-complexes
por: Seiller, Carolane, et al.
Publicado: (2020)